Monthly injectable steroid contraceptives and cervical carcinoma
Author
dc.contributor.author
Thomas, David B.
Author
dc.contributor.author
Molina, Ramiro
Author
dc.contributor.author
Cuevas, Hector Rodriguez
Author
dc.contributor.author
Ray, Roberta M.
Author
dc.contributor.author
Riotton, Gustave
Author
dc.contributor.author
Dabancens, Alfredo
Author
dc.contributor.author
Benavides, Socorro
Author
dc.contributor.author
Martinez, Luis
Author
dc.contributor.author
Salas, Oriana
Author
dc.contributor.author
Pallet, Jose A.
Author
dc.contributor.author
Lopez, Jorge
Admission date
dc.date.accessioned
2019-01-29T14:48:33Z
Available date
dc.date.available
2019-01-29T14:48:33Z
Publication date
dc.date.issued
1989
Cita de ítem
dc.identifier.citation
American Journal of Epidemiology, Volumen 130, Issue 2, 2018, Pages 237-247
Identifier
dc.identifier.issn
00029262
Identifier
dc.identifier.other
10.1093/oxfordjournals.aje.a115330
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160717
Abstract
dc.description.abstract
The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives is a large multinational hospital-based case-control study of steroid contraceptives and gynecologic, hepatobiliary, and mammary neoplasms. Monthly injectable steroid contraceptives which contained the long-acting pro-gestogen dihydroxyprogesterone acetofenide plus a shorter-acting estrogen (usually estradiol enanthate) were used by women in two of the countries (Chile and Mexico) from which data were collected. In preliminary analyses of data from Chile (1979-1983), a strong association was observed between use of these products and invasive cervical cancer. Therefore, three additional data sets from these two countries were analyzed in further detail for this report. Analyses of additional data from Chile on invasive cervical cancer (1983-1985) and cervical carcinoma in situ (1979-1986) and of data on invasive cervical cancer from Mexico (1979-1986) failed to confirm the initially observed assoc